Wei Wang

9PUBLICATIONS
8CO-AUTHORS
Molecular targetsOrthodontics and dentofacial orthopaedicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLegal institutions (incl. courts and justice systems)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 09, 2026
SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer.

|Nov 26, 2024
Transduodenal ampullectomy is an effective surgical exploration procedure for unexplained dilation of the cholangiopancreatic duct.

Wei Wang, Jie Wang, Chuanxin Yang

|Oct 09, 2024
Successful treatment of GEMOX regimen combined with nimotuzumab in the pancreatic cancer with wild KRAS and mutant BRCA: a report of two cases.

Puxiongzhi Wang, Li Zhang, Liqin Yu

|Feb 11, 2023
The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma.

Chuanxin Yang, Yaodi Shao, Xiangjun Wang

|Jan 17, 2023
Hepatolithiasis Classification Based on Anatomical Hepatectomy.

Wei Wang, Chuanxin Yang, Jie Wang

|Oct 27, 2022
Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer.

Wei Wang, Xiangjun Wang, Feng Yao

Pageof 2

Frequent Collaborators

6 joint publications

Jian Wang

5 joint publications

Chuanxin Yang

4 joint publications

Jie Wang

1 joint publications

ZiJie Zhang